FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310376952> ?p ?o ?g. }

• W4310376952 endingPage "3358" @default.
• W4310376952 startingPage "3358" @default.
• W4310376952 abstract "Osteoarthritis (OA) is a growing welfare problem for dogs and a challenge to manage for the clinician, and most therapeutic options aim to control pain. In a randomized, double-blinded, placebo-controlled, 2-way, 2-period crossover study, we aimed to evaluate the use of Blood Cell Secretome (BCS) administrated intra-articularly, with or without the combination with triamcinolone, in dogs with bilateral hip OA. BCS is an acellular orthobiologic containing anti-inflammatory and anabolic proteins produced from the patient’s own blood through extended coagulation in a defined environment. Fifteen dogs were initially assigned to a BCS group (BCSG, n = 5), a triamcinolone group (TG, n = 5), or a combination group (BCS+TG, n = 5). All had bilateral hip OA. After a 180-day follow-up, the crossover was performed with BCSG (n = 7) and BCS+TG (n = 7). BCSG received a single intra-articular administration of 3 mL of Blood Cell Secretome, and BCS+TG received BCS plus 0.5 mL of triamcinolone acetonide (40 mg/mL). The volume in BCSG was corrected to 3.5 mL with saline. In all patients, both hips were treated. For treatment follow-up, a copy of the Canine Brief Pain Inventory (divided into pain interference score—PIS and Pain Severity Score—PSS), Liverpool Osteoarthritis in Dogs (LOAD), and Canine Orthopedic Index (COI, divided into function, gait, stiffness, and quality of life) was completed on days 0, 8, 15, 30, 60, 90, 120, 150, and 180. Results were analyzed with the Mann−Whitney U test, effect size, and Kaplan−Meier estimators, followed by the log-rank test. p was set at <0.05. Patients of the sample had a mean age of 9.6 ± 2.9 years and a body weight of 29.2 ± 3.9 kg. Seven hips were classified as severe osteoarthritis, and eight were classified as moderate. No differences were found between groups at T0. Significant differences were observed in PSS scores at +8d, with BCS+TG exhibiting better results. PIS, PSS, LOAD, stiffness, and function scores were also lower in BCS+TG from +15 to +60d. The two groups showed similar improvements from +90 to +120d. Kaplan−Meier estimators showed that dogs in BCS+TG showed clinically-important differences for longer, despite a positive result in BCSG. The intra-articular administration of BCS alone was able to improve the overall condition of OA patients. Its combined use with triamcinolone acetonide lead to a faster and longer-lasting improvement in pain scores." @default.
• W4310376952 created "2022-12-10" @default.
• W4310376952 creator A5005560465 @default.
• W4310376952 creator A5016547724 @default.
• W4310376952 creator A5029687728 @default.
• W4310376952 creator A5036886112 @default.
• W4310376952 date "2022-11-30" @default.
• W4310376952 modified "2023-09-26" @default.
• W4310376952 title "A Comparison of Intra-Articular Blood Cell Secretome and Blood Cell Secretome with Triamcinolone Acetonide in Dogs with Osteoarthritis: A Crossover Study" @default.
• W4310376952 cites W1556779599 @default.
• W4310376952 cites W1946873861 @default.
• W4310376952 cites W1965665343 @default.
• W4310376952 cites W2034703952 @default.
• W4310376952 cites W2047541468 @default.
• W4310376952 cites W2078492473 @default.
• W4310376952 cites W2148693374 @default.
• W4310376952 cites W2165797485 @default.
• W4310376952 cites W2166379085 @default.
• W4310376952 cites W2197457650 @default.
• W4310376952 cites W2464325271 @default.
• W4310376952 cites W2495582442 @default.
• W4310376952 cites W2765820582 @default.
• W4310376952 cites W2796133479 @default.
• W4310376952 cites W2803012302 @default.
• W4310376952 cites W2891930494 @default.
• W4310376952 cites W2943119591 @default.
• W4310376952 cites W2953652494 @default.
• W4310376952 cites W2955666772 @default.
• W4310376952 cites W2994671347 @default.
• W4310376952 cites W3000036091 @default.
• W4310376952 cites W3010195521 @default.
• W4310376952 cites W3020587963 @default.
• W4310376952 cites W3097789630 @default.
• W4310376952 cites W3097967900 @default.
• W4310376952 cites W3120616244 @default.
• W4310376952 cites W3121881278 @default.
• W4310376952 cites W3122339729 @default.
• W4310376952 cites W3127085465 @default.
• W4310376952 cites W3159827213 @default.
• W4310376952 cites W3171007914 @default.
• W4310376952 cites W3171213078 @default.
• W4310376952 cites W4220731677 @default.
• W4310376952 cites W4220767450 @default.
• W4310376952 cites W4221076252 @default.
• W4310376952 cites W4223620674 @default.
• W4310376952 cites W4233138142 @default.
• W4310376952 cites W4253468549 @default.
• W4310376952 cites W4281630404 @default.
• W4310376952 cites W4282936426 @default.
• W4310376952 cites W4283454688 @default.
• W4310376952 cites W4291034696 @default.
• W4310376952 cites W4302293119 @default.
• W4310376952 cites W4306652906 @default.
• W4310376952 cites W4309923966 @default.
• W4310376952 cites W591545178 @default.
• W4310376952 doi "https://doi.org/10.3390/ani12233358" @default.
• W4310376952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36496879" @default.
• W4310376952 hasPublicationYear "2022" @default.
• W4310376952 type Work @default.
• W4310376952 citedByCount "0" @default.
• W4310376952 crossrefType "journal-article" @default.
• W4310376952 hasAuthorship W4310376952A5005560465 @default.
• W4310376952 hasAuthorship W4310376952A5016547724 @default.
• W4310376952 hasAuthorship W4310376952A5029687728 @default.
• W4310376952 hasAuthorship W4310376952A5036886112 @default.
• W4310376952 hasBestOaLocation W43103769521 @default.
• W4310376952 hasConcept C126322002 @default.
• W4310376952 hasConcept C141071460 @default.
• W4310376952 hasConcept C142724271 @default.
• W4310376952 hasConcept C204787440 @default.
• W4310376952 hasConcept C27081682 @default.
• W4310376952 hasConcept C2776164576 @default.
• W4310376952 hasConcept C2778903070 @default.
• W4310376952 hasConcept C42219234 @default.
• W4310376952 hasConcept C71924100 @default.
• W4310376952 hasConcept C87813604 @default.
• W4310376952 hasConceptScore W4310376952C126322002 @default.
• W4310376952 hasConceptScore W4310376952C141071460 @default.
• W4310376952 hasConceptScore W4310376952C142724271 @default.
• W4310376952 hasConceptScore W4310376952C204787440 @default.
• W4310376952 hasConceptScore W4310376952C27081682 @default.
• W4310376952 hasConceptScore W4310376952C2776164576 @default.
• W4310376952 hasConceptScore W4310376952C2778903070 @default.
• W4310376952 hasConceptScore W4310376952C42219234 @default.
• W4310376952 hasConceptScore W4310376952C71924100 @default.
• W4310376952 hasConceptScore W4310376952C87813604 @default.
• W4310376952 hasIssue "23" @default.
• W4310376952 hasLocation W43103769521 @default.
• W4310376952 hasLocation W43103769522 @default.
• W4310376952 hasLocation W43103769523 @default.
• W4310376952 hasLocation W43103769524 @default.
• W4310376952 hasLocation W43103769525 @default.
• W4310376952 hasOpenAccess W4310376952 @default.
• W4310376952 hasPrimaryLocation W43103769521 @default.
• W4310376952 hasRelatedWork W100909519 @default.
• W4310376952 hasRelatedWork W2003938723 @default.
• W4310376952 hasRelatedWork W2047967234 @default.
• W4310376952 hasRelatedWork W2118496982 @default.

• next